ConductScience.org, home

Paper12962139

Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.

Talpur N and 4 others. Mol Cell Biochem, 2003. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Papers, record 12962139. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12962139

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2003
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2026-10-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Talpur NNadeem
2Echard BBobby
3Bagchi DDebasis
4Bagchi MManashi
5Preuss HGHarry G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FruitMajor topic
Plant ExtractsMajor topic
ProstateMajor topic
Androgens
Animals
Body Weight
Cell Division
Male
Organ Size
Pollen
Rats
Secale

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112092634Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).Int Urol Nephrol2001https://conductscience.org/library/papers/12092634PubMed
21279214A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.J Urol1992https://conductscience.org/library/papers/1279214PubMed
34170194[Use of "Cernilton" in patients with prostatic hypertrophy].Hinyokika Kiyo1967https://conductscience.org/library/papers/4170194PubMed
41904229[Inhibition of arachidonic acid cascade by extract of rye pollen].Arzneimittelforschung1991https://conductscience.org/library/papers/1904229PubMed
58876706Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.Prostate1996https://conductscience.org/library/papers/8876706PubMed
61696065[Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].Hinyokika Kiyo1990https://conductscience.org/library/papers/1696065PubMed
78922564Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.Drugs Aging1996https://conductscience.org/library/papers/8922564PubMed
81283370Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.Eur Urol1992https://conductscience.org/library/papers/1283370PubMed
913928839[Preliminary research on the therapeutic effect of Cernilton on chronic prostatovesiculitis].Sven Lakartidn1962https://conductscience.org/library/papers/13928839PubMed
102692777Treatment of chronic prostatitis and prostatodynia with pollen extract.Br J Urol1989https://conductscience.org/library/papers/2692777PubMed
111689172Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia.Prostate Suppl1990https://conductscience.org/library/papers/1689172PubMed
126708534Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts.J Steroid Biochem1984https://conductscience.org/library/papers/6708534PubMed
131642680[Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism].Arzneimittelforschung1992https://conductscience.org/library/papers/1642680PubMed
147684524Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.Prostate1993https://conductscience.org/library/papers/7684524PubMed
159001839The economics of benign prostatic hyperplasia treatment: a literature review.Clin Ther1996https://conductscience.org/library/papers/9001839PubMed
168499988Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia.Br J Urol1993https://conductscience.org/library/papers/8499988PubMed
171383816The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.N Engl J Med1992https://conductscience.org/library/papers/1383816PubMed
1811582591Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats.Prostate2001https://conductscience.org/library/papers/11582591PubMed
191699628Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study.Br J Urol1990https://conductscience.org/library/papers/1699628PubMed
2011856101Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects.BJU Int2002https://conductscience.org/library/papers/11856101PubMed

See all 26 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
35847835Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.Adv Urol2022https://conductscience.org/library/papers/35847835PubMed
32481550The Effects of Aronia melanocarpa Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Rats, and Quantitative Analysis of Major Constituents Depending on Extract Conditions.Nutrients2020https://conductscience.org/library/papers/32481550PubMed
31807332Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia.Food Sci Biotechnol2019https://conductscience.org/library/papers/31807332PubMed
31623582A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model.BMC Complement Altern Med2019https://conductscience.org/library/papers/31623582PubMed
28431537The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials.BMC Urol2017https://conductscience.org/library/papers/28431537PubMed
27272436Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth.Evid Based Complement Alternat Med2016https://conductscience.org/library/papers/27272436PubMed
26816707Phytotherapy: emerging therapeutic option in urologic disease.Transl Androl Urol2012https://conductscience.org/library/papers/26816707PubMed
26106434Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract.Evid Based Complement Alternat Med2015https://conductscience.org/library/papers/26106434PubMed
24067389Fatty acid and phytosterol content of commercial saw palmetto supplements.Nutrients2013https://conductscience.org/library/papers/24067389PubMed
18038253Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.Int Urol Nephrol2007https://conductscience.org/library/papers/18038253PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12962139

GET https://conductscience.org/api/papers/v1/12962139/references?page=2